Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Sep 15.
Published in final edited form as: J Immunol. 2011 Aug 17;187(6):2849–2852. doi: 10.4049/jimmunol.1001854

Crohn’s Disease-Associated Nod2 Mutation Limits Production of Pro-Inflammatory Cytokines to Protect the Host from Enterococcus faecalis-Induced Lethality1

Yun-Gi Kim *, Michael H Shaw *, Neil Warner *, Jong-Hwan Park *,†, Felicia Chen *, Yasunori Ogura *,‡, Gabriel Núñez *
PMCID: PMC3169738  NIHMSID: NIHMS313483  PMID: 21849681

Abstract

Nod2 mutations including L1007fsinsC are associated with the development of Crohn’s disease (CD). These CD-associated Nod2 mutations are common in healthy Caucasian populations, suggesting that they may confer some protective function, but experimental evidence is lacking. Using a mouse strain that expresses Nod22939iCstop, the equivalent of the L1007fsinsC mutation, we found that macrophages homozygous for Nod22939iCstop are impaired in the recognition of MDP and E. faecalis, a commensal bacterium that is a common cause of sepsis-associated lethality in humans. Notably, Nod2 deficiency and homozygocity for Nod22939iCstop were associated with reduced production of TNF-α and IL-6 and lethality after systemic infection with E. faecalis despite normal bacteria loads. Consistently, inhibition of TNF-α Signaling protected wild-type mice from E. faecalis-induced lethality. These results suggest that the same Nod2 mutation can increase the susceptibility to CD, but also protect the host from systemic infection by a common enteric bacterium.

Introduction

Nod2, a member of the Nod-like receptor family, is activated by muramyl dipeptide (MDP), a conserved structure from bacterial peptidoglycan (1, 2). Upon MDP recognition, Nod2 induces the activation of the transcription factor NF-κB and mitogen-activated protein kinases, leading to production of pro-inflammatory and anti-microbial molecules (1–3). The importance of Nod2 is underscored by the observation that several genetic variants of Nod2 are associated with increased susceptibility to Crohn’s disease (CD)(4, 5). Three Nod2 variants, G908R, R702W and a frameshift deletion mutation at L1007 (L1007fsinsC) have been linked to CD development (4, 5). Although the precise mechanisms by which Nod2 promotes disease remain unclear, CD-associated human Nod2 variants exhibit reduced capacity to activate NF-κB following MDP stimulation (2), suggesting that the loss of Nod2 activation promotes CD.

Population studies have revealed that the main CD-associated Nod2 variants are present in ~20% of the healthy Caucasian individuals (6). Furthermore, there are marked differences in the allelic frequencies of the Nod2 variants among Caucasian populations and geographical regions in Europe (7). Because of these observations, it has been suggested that Nod2 variants linked to CD are under selection pressure possibly through bacterial infections (8). In this report, we show that Nod2 contributes to innate immune responses and regulates survival following infection with Enterococcus faecalis, an enteric commensal that is a common cause of systemic infection and lethality in humans (9). Using a newly developed mouse model in which the common CD-associated frameshift mutation was introduced into the Nod2 locus, we show that mice homozygous for the Nod2 mutation are impaired in MDP recognition and exhibit reduced susceptibility to systemic infection with E. faecalis.

Materials and Methods

Mice

C57BL/6 mice were raised in our animal facility from breeders originally purchased from Jackson Laboratories (Bar Harbor, ME). Nod2−/− miceona C57BL/6 background have been reported (10). The construction of Nod2 Leu980fs–knock-in mice was described (11). Homozygous Nod2 Leu980fs–knock-in (Nod2m/m) mice and heterozygous Nod2+/m littermates on a mixed 129–C57BL/6 background were backcrossed six times to C57BL/6 mice before used for in vivo experiments. Control wild-type mice were derived from crosses between heterozygous Nod2+/mmice backcrossed six times to C57BL/6 mice. The animal studies were conducted under approved protocols by the University of Michigan Committee on Use and Care of Animals.

Macrophage stimulation and infection

Bone-marrow derived macrophages (BMDM) were prepared as previously described (12). Lipoteichoic acid (LTA) was from Invivogen and MDP from Bachem. E. faecalis strain OG1RF (ATCC 47077) was from the American Type Culture Collection. Macrophages were infected with bacteria for 60 min at 37° C, washed twice with PBS and IMDM containing 50 μg/ml of gentamycin to limit the growth of extracellular bacteria.

HEK293T Bioassay for Nod1 and Nod2 Stimulation

Nod1 and Nod2-stimulatory was determined as previously reported (16).

Measurement of cytokines

Mouse cytokines were measured using enzyme-linked immunoabsorbent assay (ELISA) kits from R&D Systems.

Immunoblotting

Immunoblotting for mouse IκB-α, phospho-IκB-α, p38 and phospho-p38, phospho-ERK, and phospho-JNK (Cell Signaling Technology, Beverly, MA) was performed as described (10). To detect Nod2, protein extracts from mouse small intestines were immunoprecipitated using a rabbit polyclonal anti-Nod2 antibody (13), followed by immunoblotting with anti-Nod2 monoclonal antibody (13). Binding was revealed by enhanced chemiluminescence (Pierce).

Nod2 knock-in cDNA Sequencing

Total RNA extracted from BMDM was reverse transcribed and the resulting cDNA was applied as template for PCR with primers spanning Nod2 2939insC mutation (Forward: TTGAGTGTGCTCTTCGCTGT; Reverse: ACCAACCATCACGACTCCTC). Amplified products were purified by QIAEXII (Qiagen), their ends blunted with T4 DNA polymerase (Promega) and ligated into pCR-Blunt II-Topo (Invitrogen) for sequence analysis.

Mouse stimulation and infection

Adult mice (6–12 week old) were administered MDP (300 μg/mouse) by i. p. injection and serum IL-6 levels were determined 3hrs after injection. To induce endotoxin shock, mice were pre-stimulated with MDP (300 μg/mouse) i. p. and challenged with ultrapure LPS (250 μg/mouse) from E. coli O55:B5 (Sigma)i. p. 24 hours later. For infection, mice were given E. faecalis (1 × 108 CFU/animal) i. p. and bacterial loads in liver and spleen were determined by plating. TNF-α blocking IgG was a gift of T. Moore, the University of Michigan.

Statistical analysis

Statistically significant differences between two groups were determined by the two-tailed t-test with unequal variance (Aspin-Welch’s t-test). Bacterial counts of infected mice were analyzed by Man-Whitney U test. The survival rate of infected mice was analyzed using the log rank test. Differences were considered significant when p values were <0.05.

Results and Discussion

Nod2 contributes to the recognition of E. faecalis

The innate immune sensors that are involved in the recognition of E. faecalis, a common cause of infection and lethality in humans, are unknown. To assess a role for Nod2 in the recognition of E. faecalis, we first determine if products from the bacterium can induce the activation of Nod2 using an NF-κB reporter assay. The culture supernatant from E. faecalis induced robust Nod2-dependent NF-κB activation whereas extracts from the bacterial cell pellet induced little or no stimulation (Supplemental Fig. 1A). These results suggest that the bulk of the Nod2-stimulatory activity is released by the bacterium during growth. Consistent with the lack of the critical iE-DAP dipeptide motif in the PGN of E. faecalis, neither the bacterial pellet nor the culture supernatant induced Nod1-dependent NF-κB activation (Supplemental Fig. 1A). To determine whether Nod2 plays a role in the immune response to live E. faecalis, macrophages were infected with the bacterium at different bacterial/macrophage ratio and cytokine responses were measured. Infection of wild-type macrophages with E. faecalis induced the production of TNF-α and IL-6 and this response was reduced in macrophages lacking Nod2 (Fig. 1A, supplemental Fig. 1B). Consistently, phosphorylation of JNK and Iκ-Bα induced by E. faecalis infection was delayed and/or reduced in Nod2−/− macrophages, while little or no difference was detected in p38 and ERK phosphorylation (Fig. 1B, supplemental Fig. 1C). These results indicate that Nod2 contributes to the cytokine response triggered by E. faecalis in macrophages.

FIGURE 1.

FIGURE 1

Nod2 contributes to the recognition of E. faecalis. A, BMDMs from Nod2+/+ and Nod2−/− mice were infected with E. faecalis at indicated bacterial/macrophage ratio (B/M). Cell-free supernatants were analyzed for production of TNF-α 24 hrs after infection by ELISA. *, **, and *** indicate significant differences at p<0.05, p<0.01, and p<0.001, respectively. B, BMDMs from Nod2+/+ and Nod2−/− mice were infected with E. faecalis at B/M of 10 for the indicated times and assessed for MAPK and NF-κB activation using phospho specific antibodies. Results are given as means ± SD of triplicate cultures of cells from a single mouse and are representative of at least 3 independent experiments.

Nod2 deficiency protects mice from systemic infection with E. faecalis

To assess whether Nod2 regulates the susceptibility to systemic infection, wild-type and Nod2−/− mice were injected i. p. and survival was monitored over time. Notably, ~ 80 % of wild-type mice succumbed to infection as compared to only ~20% of the Nod2−/− mice (Fig. 2A). The increased survival of Nod2−/− mice was associated with reduced levels of IL-6 and TNF-α in the blood when assessed 3 hrs after infection (Fig. 2B). The reduced cytokine production was not explained by differential bacterial clearance because we found similar bacterial burden in the spleen and liver of wild-type and Nod2−/− mice (Fig. 2C, supplemental Fig. 2A). These results indicate that Nod2 regulates susceptibility to systemic infection with E. faecalis and this is associated with reduced production of TNF-α and IL-6 without affecting bacterial clearance.

FIGURE 2.

FIGURE 2

Nod2 deficiency protects mice from systemic infection with E. faecalis. A, Mouse survival over time after i. p. infection with 109E. faecalis in Nod2+/+ (n=37) and Nod2−/− mice (n=37). B, Serum IL-6 and TNF-α levels 3 hrs after infection with 109E. faecalis in Nod2+/+ and Nod2−/− mice. C, Nod2+/+ (n=5–6) and Nod2−/− mice (n=6) were infected i. p. with 108 E. faecalis. Bacterial loads were determined in the spleen of mice 1, 3, and 5 days after infection by plating. N.S. denotes not significant. D, Mouse survival over time after i.p. infection with 109E. faecalis in the presence of TNF-α blocking antibody or control IgG in wild-type mice (n=10).

TNF-α is critical for induction of lethality in mice infected with E. faecalis

Given that increased survival of Nod2−/− mice after E. faecalis infection was associated with reduced amounts of TNF-α, we asked whether inhibition of TNF-α protects mice from infection induced lethality. Infection of mice i. p. induced 100% mortality in mice treated with control IgG whereas only 20% of the mice injected with anti-TNF-α blocking antibody succumbed to infection (Fig. 2A). Treatment with anti-TNF-α antibody did not inhibit the production of TNF-α or IL-6 induced by E. faecalis infection (supplemental Fig. 2B). In contrast, administration of anti-IL-6 blocking antibody did not affect survival of mice infected with E. faecalis (supplemental Fig. 2C, 2D). The results indicate that TNF-α but not IL-6, is important for lethality associated with E. faecalis infection in our mouse model.

Mice homozygous for Nod22939iCstop mutation exhibit impaired recognition of MDP

Monocytes from individuals homozygous for the commonCD-associatedL1007fsinsC Nod2 mutation exhibit impaired cytokine response after stimulation with MDP (14). However, mouse macrophages homozygous for the equivalent L1007fsinsC Nod2 mutation displayed increased NF-κB activation in response to MDP which suggested that this genetic variant acts as a gain-of-function mutation in the mouse (15). To clarify these puzzling observations, we used a new strain of mice in which a Nod2 mutation homologous to the human L1007fsinsC was introduced into the Nod2 locus by homologous recombination (11). Sequencing of cDNA prepared from macrophages of homozygous Nod22939iCstop mice revealed the expected cytosine insertion followed by the TAG translation termination codon resulting in a truncated Nod2 protein lacking the last 33 amino acid residues (supplemental Fig. 3A, B). Immunoblotting analysis of Nod2 immunoprecipitates showed comparable levels of endogenous Nod2 in the intestinal tissue of wild-type and homozygous Nod2m/m mice (supplemental Fig. 3C). To assess the function of the Nod22939iCstop mutation, we stimulated macrophages from wild-type, Nod2−/−, and Nod2m/m mice with MDP and monitored MAPK and NF-κB activation. Stimulation of wild-type macrophages with MDP induced phosphorylation of MAPKs and IκBα which was greatly reduced or abrogated in Nod2-deficient and homozygous Nod22939iCstop macrophages (Fig. 3A). Consistently, co-stimulation of macrophages from wild-type mice with MDP and lipoteichoic acid (LTA) increased the production of TNFα and IL-6 when compared to the response observed with LTA alone, which was impaired in Nod2−/− and Nod2m/m macrophages (Fig. 3B, supplemental Fig. 3D). Furthermore, i.p. administration of MDP induced the secretion of IL-6 in the serum of wild-type mice, but not in Nod2m/m mice (Fig. 3C). To further assess the function of the Nod22939iCstop mutation in vivo, wild-type and Nod2m/m mice were injected i.p. with 300 μg of MDP and 24 hrs later with 250 μg of LPS, a protocol that promotes lethality in mice (3). Nod2m/m mice were protected from lethality induced by administration of LPS and MDP when compared to wild-type mice (Fig. 3D). These results indicate that the mouse Nod22939iCstop mutation is insensitive to MDP stimulation in vitro and in vivo.

FIGURE 3.

FIGURE 3

Mice homozygous for Nod22939iCstop mutation exhibit impaired recognition of MDP. A, BMDMs from Nod2+/+, Nod2−/− and Nod2m/m mice were stimulated with 10 μg/ml of MDP for the indicated times. Cell extracts were immunoblotted with antibodies that detect total and phosphorylated (activated) forms of the indicated proteins. Results are representative of at least three separate experiments. B, BMDMs were stimulated with 10 μg/ml LTA in the presence or absence of 10 μg/ml MDP. Cell-free supernatants were analyzed for production of TNF-α by ELISA. Results are representative of at least three separate experiments. ** denotes significant differences between cultures with and without MDP at p<0.01. C, Nod2+/+ and Nod2m/m mice (n=10 per group) were administered MDP by intraperitoneal injection. Blood samples were collected 3hrs after MDP administration and IL-6 levels were determined by ELISA. ** denotes significant differences between Nod2+/+ and Nod2m/m mice at p<0.01. D, Survival of Nod2+/+ (n=14) and Nod2m/m mice (n=9) primed with MDP (300 μg) and challenged with LPS (250 μg). The survival of each mouse genotype was monitored over time. Results are given as means ± SD.

Impaired cytokine responses induced by E. faecalis in macrophages homozygous for Nod22939iCstop mutation

We next examined the role of the Nod22939iCstop mutation in the regulation of pro-inflammatory cytokine responses after infection with E. faecalis. Infection of wild-type macrophages with E. faecalis induced secretion of IL-6 and TNF-α and these responses were significantly impaired in macrophages homozygous for the Nod22939iCstop mutation (Fig. 4A). As a comparison, Nod2−/− and homozygous Nod22939iCstop macrophages produced comparable amounts of IL-6 and TNF-α in response to bacterial infection which was lower than in wild-type macrophages (Fig. 4A, supplemental Fig. 4). These results indicate that the Nod22939iCstop mutation is associated with defective recognition of E. faecalis in macrophages.

FIGURE 4.

FIGURE 4

Nod22939iCstop homozygocity is associated with reduced response to E. faecalis in vitro and in vivo. A, BMDMs from Nod2+/+, Nod2−/− and Nod2m/m mice were infected with E. faecalis at indicated bacterial/macrophage ratio (B/M). Cell-free supernatants were analyzed for production of TNF-α by ELISA. *, **, and *** indicate significant differences at p<0.05, p<0.01, and p<0.001, respectively. B, Mouse survival over time after infection of wild-type, Nod2+/m and Nod2m/m mice with 109E. faecalis. C, Serum IL-6 and TNF-α levels 3 hrs after infection of indicated mice with 109E. faecalis. Results are given as means ± SD.

Reduced susceptibility to systemic infection with E. faecalis in mice homozygous for Nod22939iCstop mutation

We next examined the susceptibility of wild-type and Nod2m/mmice to i. p. administration of E. faecalis. In these experiments, we crossed heterozygous Nod2+/m mice with homozygous Nod2m/m mice to generate littermate mice heterozygous and homozygous for the Nod22939iCstop mutation. We then challenged wild-type as well as heterozygous Nod2+/m and homozygous Nod2m/m littermatesi. p. with E. faecalis and assessed cytokine production and mouse survival overtime. Nod2m/m mice exhibited increased survival compared to wild-type mice (67% vs 25%, p= 0.05) after i. p. challenge with E. faecalis (Fig. 4B). In contrast, heterozygous Nod2+/m and wild-type mice exhibited comparable survival after bacterial challenge (Fig. 4B). The increased survival of Nod2m/m mice was associated with reduced serum levels of IL-6 and TNF-α (Fig. 4C). These results indicate that homozygocity for the Nod22939iCstop mutation promotes survival after systemic infection with E. faecalis.

Using a newly developed model of the L1007fsinsC Nod2 mutation, we show that the resulting Nod2 truncated protein is impaired in MDP recognition and thus behaving as a loss-of-function mutation similar to that found in human cells (2, 14). There is no a clear explanation to account for the differences in results between our model and the model published by Maeda et al. (15). In contrast to our animal model, a TAG termination codon was not introduced after the cytosine insertion at position 2939 in the model reported by Maeda et al. which is predicted to result in a frameshift mutation leading to the addition of 42 amino acids not present in the CD-associated or normal Nod2 protein. Thus, it is possible that differences in the resulting Nod2 mutant protein between the two models could explain, at least in part, the discrepancy in results. We show here that mice homozygous for the CD-associated Nod22939iCstop mutation displayed impaired production of pro-inflammatory cytokines and improved survival in response to systemic infection with E. faecalis. These results suggest that the CD-associated Nod22939iCstop mutation exhibits a dual function. Namely, it promotes the susceptibility to CD, but also protects the host by limiting the production of harmful cytokines induced by systemic infection with E. faecalis. Because MDP synergizes with TLR ligands in the production of pro-inflammatory cytokines, it is likely that the role for Nod22939iCstop mutation in limiting the production of harmful cytokines and lethality in response to bacterial infection is not limited to E. faecalis. However, most studies to date have shown increased susceptibility of Nod2−/− mice to infections with microbial pathogens (16). Thus, the contribution of Nod2 mutations in evolutionarily selecting for individuals who are L1007fsinsC remains unclear.

Supplementary Material

1

Acknowledgments

The authors are grateful to Richard Flavell for Nod2−/− mice, Joel Whitfield from the Cellular Immunology Core Facility of the University of Michigan Cancer Center for ELISA assays, Sharon Koonse for animal husbandry, and Mizuho Hasegawa for advise.

Abbreviations used in this paper

BMDM

bone marrow derived macrophages

CD

Crohn’s disease

MDP

muramyl dipeptide

Nod2

Nucleotide-binding oligomerization domain 2

TLR

Toll-like receptors

Footnotes

1

This work was supported by NIH grant R01 DK61707. Y.-G. Kim was supported by training funds from the University of Michigan Comprehensive Cancer Center and M. H. Shaw by a Fellowship from US National Institutes of Health (T32-HL007517).

Disclosures

The authors declare that no competing interest exist.

References

  • 1.Girardin SE, I, Boneca G, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869–8872. doi: 10.1074/jbc.C200651200. [DOI] [PubMed] [Google Scholar]
  • 2.Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem. 2003;278:5509–5512. doi: 10.1074/jbc.C200673200. [DOI] [PubMed] [Google Scholar]
  • 3.Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731–734. doi: 10.1126/science.1104911. [DOI] [PubMed] [Google Scholar]
  • 4.Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603. doi: 10.1038/35079107. [DOI] [PubMed] [Google Scholar]
  • 5.Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606. doi: 10.1038/35079114. [DOI] [PubMed] [Google Scholar]
  • 6.Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M, Schreiber S, Annese V, Jewell DP, Fowler EV, Brant SR, Silverberg MS, Cho J, Rioux JD, Satsangi J, Parkes M. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol. 2007;102:1259–1267. doi: 10.1111/j.1572-0241.2007.01149.x. [DOI] [PubMed] [Google Scholar]
  • 7.Cavanaugh J. NOD2: ethnic and geographic differences. World J Gastroenterol. 2006;12:3673–3677. doi: 10.3748/wjg.v12.i23.3673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gasche C, Nemeth M, Grundtner P, Willheim-Polli C, Ferenci P, Schwarzenbacher R. Evolution of Crohn’s disease-associated Nod2 mutations. Immunogenetics. 2008;60:115–120. doi: 10.1007/s00251-008-0274-6. [DOI] [PubMed] [Google Scholar]
  • 9.Goossens H. The epidemiology of vancomycin-resistant enterococci. Curr Opin Infect Dis. 1999;12:537–541. doi: 10.1097/00001432-199912000-00002. [DOI] [PubMed] [Google Scholar]
  • 10.Kim YG, Park JH, Shaw MH, Franchi L, Inohara N, Nunez G. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity. 2008;28:246–257. doi: 10.1016/j.immuni.2007.12.012. [DOI] [PubMed] [Google Scholar]
  • 11.Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG, Yuan L, Soares F, Chea E, Le Bourhis L, Boneca IG, Allaoui A, Jones NL, Nunez G, Girardin SE, Philpott DJ. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11:55–62. doi: 10.1038/ni.1823. [DOI] [PubMed] [Google Scholar]
  • 12.Celada A, Gray PW, Rinderknecht E, Schreiber RD. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med. 1984;160:55–74. doi: 10.1084/jem.160.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J, Greenson JK, Keshav S, Nunez G. Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis. Gut. 2003;52:1591–1597. doi: 10.1136/gut.52.11.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, Ahmad T, McGovern DP, Onnie C, Negoro K, Goldthorpe S, Foxwell BM, Mathew CG, Forbes A, Jewell DP, Playford RJ. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn’s disease. Lancet. 2005;365:1794–1796. doi: 10.1016/S0140-6736(05)66582-8. [DOI] [PubMed] [Google Scholar]
  • 15.Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, Eckmann L, Karin M. Nod2 mutation in Crohn’s disease potentiates NF-kappaB activity and IL-1beta processing. Science. 2005;307:734–738. doi: 10.1126/science.1103685. [DOI] [PubMed] [Google Scholar]
  • 16.Shaw MH, Kamada N, Warner N, Kim YG, Nunez G. The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol. 2011;32:73–79. doi: 10.1016/j.it.2010.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES